A5020787012- Health Systems, Economic Evaluations, Quality of Life
- Social and Educational Sciences
- Dementia and Cognitive Impairment Research
- Inflammatory Bowel Disease
- Research in Social Sciences
- Historical and Archaeological Studies
- Microscopic Colitis
- Pharmaceutical Economics and Policy
- Folklore, Mythology, and Literature Studies
- Grief, Bereavement, and Mental Health
- Education, Healthcare and Sociology Research
- Multiple Sclerosis Research Studies
- Disability Education and Employment
- Global Health Care Issues
- Family and Disability Support Research
- Musculoskeletal pain and rehabilitation
- Liver Diseases and Immunity
- Occupational Therapy Practice and Research
- Frailty in Older Adults
- Aging, Elder Care, and Social Issues
- Autoimmune and Inflammatory Disorders
- Disability Rights and Representation
- Media, Religion, Digital Communication
- Education, sociology, and vocational training
- Healthcare innovation and challenges
Quantify Research (Sweden)
2016-2025
Karolinska Institutet
2016-2025
Stockholm University
2007-2023
University of Oslo
2002-2023
Karlstad Central Hospital
2019-2020
Uppsala University
1981-2020
Royal Australasian College of Surgeons
2020
The University of Adelaide
2020
New York University Press
2020
Cambridge University Press
2020
Background and purpose: In 2005, we presented for the first time overall estimates of annual costs brain disorders (mental neurologic disorders) in Europe. This new report presents updated, more accurate, comprehensive 2010 30 European countries. Methods: One‐year prevalence cost per person 19 major groups are based on ‘best estimates’ derived from systematic literature reviews by panels experts epidemiology health economics. Our estimation model was populated with national statistics...
Headache disorders are very common, but their monetary costs in Europe unknown. We performed the first comprehensive estimation of how economic resources lost to headache Europe. From November 2008 August 2009, a cross-sectional survey was conducted eight countries representing 55% adult EU population. Participation rates varied between 11% and 59%. In total, 8412 questionnaires contributed this analysis. Using bottom-up methodology, we estimated direct (medications, outpatient health care,...
Abstract Introduction Global estimates on numbers of persons in early stages Alzheimer's disease (AD), including prodromal and preclinical, are lacking, yet needed to inform policy decisions preventive measures planning for future therapies targeting AD pathology. Methods We synthesized the literature prevalence across continuum derived a model estimating number persons, stratified by 5‐year age groups, sex, stage (AD dementia, AD, preclinical AD). Results The global with were estimated at...
Care for demented people is very resource demanding, the prevalence increasing and there so far no cure. Cost of illness (CoI) studies are important by identifying distribution costs between different payers care. The European Union (EU) funded Collaboration on Dementia (Eurocode) as part EU's 2005 work plan Community public health programme. Eurocode was administered Alzheimer Europe. aim to describe economic impact dementia in Europe 2008.Eurocode's new estimates were included a cost model...
Aliment Pharmacol Ther 2010; 32: 1154–1162 Summary Background Reliable epidemiological data for portal vein thrombosis are lacking. Aims To investigate the incidence, prevalence and survival rates patients with thrombosis. Methods Retrospective multicentre study of all registered diagnosis between 1995 2004. Results A total 173 (median age 57 years, 93 men) were identified followed up a median 2.5 years (range 0–9.7). The mean age‐standardized incidence 0.7 per 100 000 year 3.7 inhabitants,...
Abstract Background Chronic pain constitutes a substantial socio‐economic challenge but little is known about its actual cost. Aim To estimate the direct and indirect costs of patients with diagnosis related to chronic ( DRCP ), determine variation in these across different groups, identify what resources constitute most important components costs. Methods Patient level data from three administrative registries Västra Götalandsregionen Sweden including inpatient outpatient care,...
Abstract Background: The exact incidence and prevalence of Budd‐Chiari syndrome (BCS) is unknown in the general population. Published reports differ terms clinical characteristics, effects therapy survival. Aims: To investigate epidemiology, presentation survival patients with BCS. Methods: Retrospective multicentre study Sweden reviewing medical records all BCS 1986–2003, identified from computerised diagnosis database 11 hospitals, including university hospitals liver transplantation...
Summary Background Bowel strictures are a major cause of morbidity, hospitalisation and surgery in C rohn's disease. Aim We report short‐ long‐term efficacy safety endoscopic balloon dilation due to Crohn's Methods Retrospective study patients who underwent between 1987 2009. Results performed 776 dilations, which 621 (80%) were on anastomotic strictures, 178 (94 women) with At first dilation, median ( IQR ) age was 45 (37–56) years disease duration 16 (8–22) years. Technical success rate...
The costs of care for patients with Alzheimer's disease are correlated key measures severity. This relationship is important in the economic evaluation new treatments and used to translate treatment efficacy into effects on through modeling. We aimed identify what severity most predictors societal whether their differs across countries.Interviews were conducted 1222 patient caregiver pairs residing community or residential settings Spain, Sweden, United Kingdom, States. Assessments included...
Abstract Background Chronic pain is a condition with severe impact on many aspects of life, including work, functional ability and quality thereby reducing physical, mental social well‐being. Despite the high prevalence burden chronic pain, it has received disproportionally little attention in research public policy societal costs remain largely unknown. This study aimed to describe long‐term healthcare work absence individuals without self‐identified pain. Methods The population were...
ABSTRACT Background: Cognition, abilities in activities of daily living (ADL), and behavioral disturbances patients with Alzheimer's disease (AD) all influence the number hours informal caregivers spend caring for their patients, burden experience. However, direct effect relative importance each severity measure remains unclear. Methods: Cross-sectional interviews were conducted 1,222 AD primary Spain, Sweden, U.K. U.S.A. Assessments included care hours, caregiver (Zarit Burden Inventory;...
Background: Multiple sclerosis (MS) is a common cause of neurological disability in young adults. The TRIBUNE study provides detailed exploration costs relation to relapses and disease severity, assesses the quality life impact on MS patients terms utilities, fatigue activities daily living (ADL). Methods: Patients five European countries (France, Germany, Italy, Spain United Kingdom) completed self-administered web-based questionnaire capturing information demographics, characteristics...
This study addresses how help is provided for pupils with physical disabilities and school assistants influence their participation in school. Data were collected through field observations interviews seven between 7 15 years old each pupil's teacher assistant. The analysis resulted a description of features that influenced was the consequences pupil disabilities. A major finding could both facilitate hinder participation. We concluded an awareness priority place on social peers needed to...
Endoscopic balloon dilation is an efficacious and safe alternative to surgery as treatment of short intestinal strictures in Crohn's disease (CD). Factors predicting outcome the procedure are not well described.To evaluate whether smoking at diagnosis, with azathioprine, or other clinical variables may affect after endoscopic dilation. The endpoint was requirement a new intervention such resection strictureplasty.Retrospective study 83 patients CD who underwent stricture between 1987...
Abstract Introduction We develop a framework to model disease progression across Alzheimer's (AD) and assess the cost‐effectiveness of future disease‐modifying therapies (DMTs) for people with mild cognitive impairment (MCI) due AD. Methods Using data from US National Coordinating Center, we apply survival analysis estimate transition predementia AD dementia ordered probit regression transitions stages. investigate hypothetical treatment scenario in MCI Results present an open‐access...
Abstract Background In this study, we sought to estimate the societal cost of illness in dementia Sweden 2012 using different costing approaches highlight methodological issues. Methods We conducted a prevalence-based cost-of-illness study with perspective. Results The costs were SEK 62.9 billion (approximately €7.2 billion, approximately US$9.0 billion) or 398,000 per person €45,000, US$57,000). By far most important item is institutional care: about 60% costs. sensitivity analysis,...